NEW YORK (GenomeWeb) – Amid growing evidence pointing to the prognostic potential of microRNAs in circulating tumor cells (CTCs), researchers from GENYO — the Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research in Spain — reported this month a technique for detection of the small, non-coding RNAs in CTCs using in situ hybridization.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.